Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
QuintilesIMS
Julphar
Federal Trade Commission
Fish and Richardson
Cantor Fitzgerald
Baxter
Covington

Generated: April 23, 2018

DrugPatentWatch Database Preview

RENOQUID Drug Profile

« Back to Dashboard

When do Renoquid patents expire, and what generic alternatives are available?

Renoquid is a drug marketed by Glenwood and is included in one NDA.

The generic ingredient in RENOQUID is sulfacytine. Additional details are available on the sulfacytine profile page.
Drug patent expirations by year for RENOQUID
Synonyms for RENOQUID
1-Ethyl N4-sulfanilylcytosin
1-Ethyl-N-sulfanilylcytosine
11126-44-6
1401-49-6
17784-12-2
4-Amino-N-(1-ethyl-2-oxo-1,2-dihydro-4-pyrimidinyl)benzenesulfonamide #
4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzene-1-sulfonamide
4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzenesulfonamide
4-amino-N-(1-ethyl-2-oxo-pyrimidin-4-yl)benzenesulfonamide
4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide
AC1L1K3H
AC1Q6C6O
ACM17784122
AN-5707
API0004261
Benzenesulfonamide, 4-amino-N-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
Benzenesulfonamide,2-dihydro-2-oxo-4-pyrimidinyl)-
CAS-17784-12-2
CHEBI:135230
CHEMBL1201056
CI 636
CI-636
CL 636
D02519
D0T1GT
DB01298
DSSTox_CID_3606
DSSTox_GSID_23606
DSSTox_RID_97550
DTXSID6023606
FT-0710995
HE059066
HE319183
HSDB 3272
LS-173691
N-Sulfanilyl-1-ethylcytosine
N-Sulfanilyl-l-ethylcytosine
N(sup 1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide
N(sup1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide
N1-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide
NCGC00253598-01
Nl-sulfanilyl-1-ethylcytosine
NSC 356717
NSC-356717
NSC356717
Renoquid (TN)
SCHEMBL49377
SIBQAECNSSQUOD-UHFFFAOYSA-N
Sulfacitina
Sulfacitina [INN-Spanish]
Sulfacitine
Sulfacitinum
Sulfacitinum [INN-Latin]
sulfacytine
Sulfacytine (USAN)
Sulfacytine [USAN:BAN]
Sulfacytine [USAN:INN:BAN]
Sulfanilamide, N(1)-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- (8CI)
Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-(8CI)
Sulfanilamide,2-dihydro-2-oxo-4-pyrimidinyl)-
T795873AJP
Tox21_113734
UNII-T795873AJP
ZINC2092

US Patents and Regulatory Information for RENOQUID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenwood RENOQUID sulfacytine TABLET;ORAL 017569-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Healthtrust
QuintilesIMS
Merck
Johnson and Johnson
Citi
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.